- September 27, 2021OHSU startup, Inherent Targeting, is among the Pacific Northwest-based startups selected to present at the Pacific Northwest Startup Showcase & Social on Tuesday, October 12 from 10am-12pm. Inherent Targeting improves surgical outcomes with high contrast, nerve-specific fluorescent dyes that help surgeons visualize buried nerves and distinguish them from surrounding tissue. This reduces patient
- September 02, 2021In 2020, the Oregon Clinical & Translational Research Institute (OCTRI) awarded Jessica Grant, an OHSU speech therapist, and David Sheridan, MD, an OCTRI Scholar and OHSU associate professor of emergency medicine, a Biomedical Innovation Program award for their device called the Koala Kushion. This week, the duo was interviewed for OHSU's Innovator Spotlight series. Read more about their progress
- July 26, 2021In collaboration with the Technology Transfer and Collaborations & Entrepreneurship offices at Oregon Health & Science University (OHSU), the Oregon Clinical and Translational Research Institute (OCTRI) announced three new funded projects for the 2021 drug discovery track of the Biomedical Innovation Program. This program supports drug discovery platforms and early-stage therapeutic technology
- June 28, 2021
Government, non-profits, and organizations fund research with the ultimate goal of improving health and society. Yet measuring these long-term outcomes can be challenging, and research impact has traditionally been tied to quantitative productivity, like bibliometrics and grant funding, and not necessarily the broader impacts of research. For years, researchers lacked a cohesive framework to
- March 08, 2021OCTRI Scholar Dr. David Sheridan (left) and Dr. Matthew Hansen (right), both OHSU Emergency Medicine physicians, were awarded OCTRI Biomedical Innovation Program (BIP) funding and project support in 2018 to develop a new bedside technology for quickly detecting sepsis using an accurate and objective measure of capillary refill time (CRT). In the last 3 years, Drs. Sheridan and Hansen leveraged
- January 25, 2021A team of researchers led by Dr. Dora M. Raymaker, one of few openly autistic researchers, used a community-based participatory research (CBPR) approach to conduct an inaugural study on autistic burnout. Findings draw attention to the syndrome, long recognized by autistic people but not formally investigated, and will inform future research, prevention strategies, and interventions. Autistic
- January 25, 2021Navigating the daunting landscape of childhood cancer is getting easier for patients and families thanks to the work of the OCTRI Health Experiences Research Network (HERN) and former OCTRI TL1 scholar Kellee Parker, DO. The OCTRI HERN team conducted 40 interviews with families of childhood cancer survivors to gain insight into the experience childhood cancer. Findings from these interviews
- December 22, 2020In collaboration with the Technology Transfer and Collaborations & Entrepreneurship offices at Oregon Health & Science University (OHSU), the Oregon Clinical and Translational Research Institute (OCTRI) announced four new funded projects for the 2021 device and diagnostics track of the Biomedical Innovation Program. This program cultivates, evaluates, and funds promising translational projects
- September 23, 2020
The Tillamook County Wellness (TCW) coalition, of which the Oregon CTSA (OCTRI) is a member and key supporter, scored a big win recently when Tillamook Adventist Health’s newly-created Community Well-Being Division absorbed TCW’s Wellness Coordinator position – as well as the person filling it – to head Adventist’s new Division. This move was an important step, because it confirms the importance
- August 21, 2020Dr. Amala Soumyanath, a former Oregon CTSA (OCTRI) scholar at Oregon Health & Science University, will establish and lead a botanical research center to study the properties of herbs traditionally used in dietary supplements to improve sleep and mood, and delay cognitive decline in aging. The research will inform high-quality clinical trials by increasing knowledge about the active compounds and
- August 07, 2020The Oregon Clinical & Translational Clinical Research Institute (OCTRI) at Oregon Health & Science University (OHSU) funded three projects for their 2020 Biomedical Innovation Program drug discovery track. The funded research covers pancreatic cancer, prostate cancer, and SARS-CoV-2. This category of funding supports drug discovery platforms and early-stage therapeutic technology projects
- Oregon Health and Science University
The Oregon Clinical & Translational Research Institute (OCTRI) Recruitment team pivoted its efforts early on during the COVID pandemic in order to support clinical and translational scientists in navigating the research shutdown (and now the restart of research) at Oregon Health and Science University (OHSU).
- June 18, 2020
OCTRI announces six awardees to two tracks of the Biomedical Innovation Program: COVID-19 Rapid Response and Digital Health.
- April 26, 2020Two Emergency Medicine faculty researchers at Oregon Health and Science University are looking for healthcare workers to take their research survey on the impact of COVID-19 on the healthcare workforce. This is a CTSA-supported study. See below. Are you a healthcare worker that comes in contact with patients? Concerned about COVID-19’s impact on the healthcare workforce? Participate in an
- April 13, 2020The Oregon Clinical & Translational Research Institute (OCTRI) at Oregon Health & Science Universtiy (OHSU) pivoted rapidly to support our home institution and our state during this crisis. Our rapid response allowed us to become the central organizing and triage hub for clinical research during this time. This provided us the opportunity to demonstrate our value to OHSU and also to utilize the
- February 12, 2020
The Center for Evidence-based Policy at Oregon Health & Science University (OHSU) recently launched CLOUD: Curated Library about Opioid Use for Decision-makers. CLOUD is a user-friendly, online repository of evidence-based, actionable materials on opioids and the opioid crisis. The opioid library has three specific audiences in mind: payers & providers, policymakers & community leaders, and
- Oregon Health and Science University
This video provides a brief overview of sampling constructs in qualitative research.
- February 12, 2020
Dr. Amanda Bruegl, OHSU oncologist and OCTRI KL2 awardee, has been named a scholar of the Harold Amos Medical Faculty Development Program, which is part of The Robert Wood Johnson Foundation. Dr. Bruegl will leverage this prestigious award to expand her research on HPV and cervical cancer in Native American women.
- January 13, 2020
Meet Dr. Rebecca Spain, a neurologist at OHSU.